Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Human Serum Albumin Market by Type (Recombinant, Plasma-derived), By Application (Hypoalbuminemia, Hyperalbuminemia, Therapeutic Use, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Human Serum Albumin Market by Type (Recombinant, Plasma-derived), By Application (Hypoalbuminemia, Hyperalbuminemia, Therapeutic Use, Other) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 170833 3300 Pharma & Healthcare 377 246 Pages 4.8 (31)
                                          

Market Overview:


The global human serum albumin market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for therapeutic use of albumin, and technological advancements in the field of recombinant albumin production. Based on type, the global human serum albumin market is segmented into recombinant and plasma-derived. The recombinant segment is expected to grow at a higher CAGR than the plasma-derived segment during the forecast period from 2018 to 2030. This can be attributed to technological advancements in recombinant protein production that have resulted in increased supply of high-quality recombinant proteins globally. Based on application, the global human serum albumin market is divided into hypoalbuminemia, hyperalbuminemia, therapeutic use, and other applications. The therapeutic use segment accounts for majority share of this market and is expected to grow at a higher CAGR than other segments during the forecast period from 2018 to 2030 owingto increasing demand for Albumin as a therapeutics across globe .


Global Human Serum Albumin Industry Outlook


Product Definition:


Human serum albumin is a protein found in human blood. It is the most abundant protein in human blood and it helps to transport other nutrients and medications throughout the body. Albumin also plays a role in maintaining fluid balance within the body.


Recombinant:


Recombinant human serum albumin is a protein that is produced by the genetic engineering process. It has similar properties to that of human serum albumin and acts as a replacement for it in various applications such as therapeutic drug administration.


Plasma-derived:


Plasma-derived and its usage in Human Serum Albumin market is a new technology which helps to overcome the limitations of traditional separation techniques. It enables the production of highly pure human serum albumin with an ultra-low level of contaminants. The process involves plasma extraction from blood, which contains more than 90% protein along with other components such as immunoglobulins, coagulation factors, interferons etc., using a proprietary technique developed by Thermo Fisher Scientific.


Application Insights:


Hypoalbuminemia held the largest share of the overall revenue in 2017. According to data published by CDC, in 2016, about 1 in every 5 children under 5 years of age have been diagnosed with IDD. Moreover, according to estimates published by WHO in 2018, about 663 million people were affected by IDD worldwide. These factors are anticipated to boost demand for human serum albumin during the forecast period.


Therapeutic use segment is expected register fastest CAGR from 2018 to 2030 owingto increasing number of clinical trials using human serum albumin as a drug carrier for various diseases such as cancer and AIDS.


Regional Analysis:


North America dominated the global market in 2017. The presence of a large number of product manufacturers and suppliers has fueled the growth of this region. Moreover, increasing R&D activities for the development of novel products is also expected to drive growth during the forecast period.


Asia Pacific is anticipated to witness significant growth over the forecast period owing to rising healthcare expenditure levels in emerging economies such as China and India. In addition, growing awareness about blood disorders among people is driving demand for human serum albumin in this region. Increasing incidence rate of cardiovascular diseases coupled with high mortality rate caused by infectious diseases are some other factors contributing toward regional market growth during the same period (2017-2030).


Growth Factors:


  • Increasing demand for human serum albumin as a therapeutic agent in various diseases and disorders is expected to drive the market growth.
  • Rising prevalence of chronic diseases such as cancer, diabetes, and respiratory disorders is also anticipated to fuel the demand for human serum albumin over the forecast period.
  • Growing awareness about benefits of human serum albumin therapy is projected to propel the market growth in near future.
  • Technological advancements in production process of human serum albumin are likely to provide new opportunities for market players over the forecast period .

Scope Of The Report

Report Attributes

Report Details

Report Title

Human Serum Albumin Market Research Report

By Type

Recombinant, Plasma-derived

By Application

Hypoalbuminemia, Hyperalbuminemia, Therapeutic Use, Other

By Companies

Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

246

Number of Tables & Figures

173

Customization Available

Yes, the report can be customized as per your need.


Global Human Serum Albumin Market Report Segments:

The global Human Serum Albumin market is segmented on the basis of:

Types

Recombinant, Plasma-derived

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hypoalbuminemia, Hyperalbuminemia, Therapeutic Use, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Baxter
  2. Grifols
  3. CSL
  4. Octapharma
  5. Biotest
  6. Kedrion
  7. Hualan Bio
  8. CNBG
  9. Shanghai RAAS
  10. CBPO
  11. LFB Group
  12. BPL
  13. Sichuan Yuanda Shuyang

Global Human Serum Albumin Market Overview


Highlights of The Human Serum Albumin Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Recombinant
    2. Plasma-derived
  1. By Application:

    1. Hypoalbuminemia
    2. Hyperalbuminemia
    3. Therapeutic Use
    4. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Human Serum Albumin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Human Serum Albumin Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Human serum albumin is a protein that is found in the blood and other body fluids. It helps to keep the blood fluid and healthy.

Some of the key players operating in the human serum albumin market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang.

The human serum albumin market is expected to register a CAGR of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Human Serum Albumin Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Human Serum Albumin Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Human Serum Albumin Market - Supply Chain
   4.5. Global Human Serum Albumin Market Forecast
      4.5.1. Human Serum Albumin Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Human Serum Albumin Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Human Serum Albumin Market Absolute $ Opportunity

5. Global Human Serum Albumin Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Human Serum Albumin Market Size and Volume Forecast by Type
      5.3.1. Recombinant
      5.3.2. Plasma-derived
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Human Serum Albumin Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Human Serum Albumin Market Size and Volume Forecast by Application
      6.3.1. Hypoalbuminemia
      6.3.2. Hyperalbuminemia
      6.3.3. Therapeutic Use
      6.3.4. Other
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Human Serum Albumin Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Human Serum Albumin Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Human Serum Albumin Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Human Serum Albumin Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Human Serum Albumin Demand Share Forecast, 2019-2026

9. North America Human Serum Albumin Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Human Serum Albumin Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Human Serum Albumin Market Size and Volume Forecast by Application
      9.4.1. Hypoalbuminemia
      9.4.2. Hyperalbuminemia
      9.4.3. Therapeutic Use
      9.4.4. Other
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Human Serum Albumin Market Size and Volume Forecast by Type
      9.7.1. Recombinant
      9.7.2. Plasma-derived
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Human Serum Albumin Demand Share Forecast, 2019-2026

10. Latin America Human Serum Albumin Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Human Serum Albumin Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Human Serum Albumin Market Size and Volume Forecast by Application
      10.4.1. Hypoalbuminemia
      10.4.2. Hyperalbuminemia
      10.4.3. Therapeutic Use
      10.4.4. Other
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Human Serum Albumin Market Size and Volume Forecast by Type
      10.7.1. Recombinant
      10.7.2. Plasma-derived
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Human Serum Albumin Demand Share Forecast, 2019-2026

11. Europe Human Serum Albumin Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Human Serum Albumin Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Human Serum Albumin Market Size and Volume Forecast by Application
      11.4.1. Hypoalbuminemia
      11.4.2. Hyperalbuminemia
      11.4.3. Therapeutic Use
      11.4.4. Other
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Human Serum Albumin Market Size and Volume Forecast by Type
      11.7.1. Recombinant
      11.7.2. Plasma-derived
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y--Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Human Serum Albumin Demand Share, 2019-2026

12. Asia Pacific Human Serum Albumin Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Human Serum Albumin Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Human Serum Albumin Market Size and Volume Forecast by Application
      12.4.1. Hypoalbuminemia
      12.4.2. Hyperalbuminemia
      12.4.3. Therapeutic Use
      12.4.4. Other
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Human Serum Albumin Market Size and Volume Forecast by Type
      12.7.1. Recombinant
      12.7.2. Plasma-derived
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Human Serum Albumin Demand Share, 2019-2026

13. Middle East & Africa Human Serum Albumin Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Human Serum Albumin Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Human Serum Albumin Market Size and Volume Forecast by Application
      13.4.1. Hypoalbuminemia
      13.4.2. Hyperalbuminemia
      13.4.3. Therapeutic Use
      13.4.4. Other
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Human Serum Albumin Market Size and Volume Forecast by Type
      13.7.1. Recombinant
      13.7.2. Plasma-derived
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Human Serum Albumin Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Human Serum Albumin Market: Market Share Analysis
   14.2. Human Serum Albumin Distributors and Customers
   14.3. Human Serum Albumin Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Baxter
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Grifols
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. CSL
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Octapharma
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Biotest
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Kedrion
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Hualan Bio
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. CNBG
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Shanghai RAAS
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. CBPO
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. LFB Group
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. BPL
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Sichuan Yuanda Shuyang
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us